✦ LIBER ✦

Treatment of advanced breast cancer with 20 mg toremifene, a phase II study. Preliminary communication

✍ Scribed by S. Pyrhönen; R. Valavaara; M. Heikkinen; P. Rissanen; G. Blanco; E. Nordman; L.R. Holsti; A. Hajba

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II clinical study of toremifene in

✍ H. Modig; S. Borgström; I. Nilsson; G. Westman 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 135 KB

Phase II clinical study of high-dose tor

✍ H. Modig; S. Borgström; I. Nilsson; G. Westman 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 139 KB

PP-7-10 A phase II trial on high dose (2

✍ D. Baltina; T. Hietanen; R. Johamsson; S. Numminen; T. Hakala; L. Helle; R. Vala 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 181 KB

Bendamustine as salvage treatment in pat

✍ K. Höffken; Kh. Merkle; M. Schönfelder; G. Anger; M. Brandtner; K. Ridwelski; S. 📂 Article 📅 1998 🏛 Springer-Verlag 🌐 English ⚖ 212 KB

High dose toremifene (240 mg daily) is e

✍ Tenho Hietanen; Dace Baltina; Risto Johansson; Soile Numminen; Tapani Hakala; Le 📂 Article 📅 1990 🏛 Springer US 🌐 English ⚖ 273 KB

Chemotherapy with estrogenic recruitment

✍ R. Paridaens; J.Blonk van der Wijst; J.P. Julien; E. Ferrazzi; A. Clarysse; J.C. 📂 Article 📅 1983 🏛 Elsevier Science 🌐 English ⚖ 97 KB